GTx C-6 | The Contraceptive Pipeline Database

Product Overview

Alternative Name: SARM C-6

Development Status: Inactive

Target: Male

Mode: Hormonal

Delivery Type: Oral

Duration Type: Short-acting

Description: (S)-3(4-chloro-3fluorophenoxy)-2-hydroxy-2methyl-N-(4nitro-3-trifluoromethylphenyl) propionamide, or GTx C-6, is a selective androgen receptor modulator (SARM). It is thought to have a combination of activity that inhibits spermatogenesis but maintains sexual function, libido and muscle mass.

Updated date: July 20, 2016

Vertical Tabs

Product Details

Active Pharmaceutical Ingredient (API): (S)-3(4-chloro-3fluorophenoxy)-2-hydroxy-2methyl-N-(4nitro-3-trifluoromethylphenyl) propionamide [GTx C-6]

Potential Multi-Purpose Technology (MPT): No

Partner: GTx, Inc., Memphis, TN

Status

Project Phase: Early Development

Project Stage: Pre-clinical

Status Details:
Development of the compound as a male contraceptive agent not currently being pursued by GTx.

Programmatic Considerations

Additional Information

Additional Information:
Chen J, Hwang DJ, et al. (2004) A Selective Androgen Receptor Modulator for Hormonal Male Contraception. Journal of Pharmacology and Experimental Therapeutics; 312(2).

Download Product Report